TXNRD1 and cancer: The negative correlations to TrxR (TXNRD1) expression by reported TrxR-Trx inhibitory compounds [10,11,15,19,137], as well as by compounds with very strong similarities in anti-cancer activity, suggest that the cytotoxicity of these compounds is greater when TrxR levels are low (Table 1).